NQMC Update Service: September 2, 2013

September 2, 2013 New This Week Measure Summaries National Committee for Quality Assurance Adherence to antipsychotic medications for individuals with schizophrenia: percentage of members 19 to 64 years of age with schizophrenia during the measurement year who were dispensed and remained on an antipsychotic medication for at least 80 percent of their treatment period. Annual monitoring for patients on persistent medications: percentage of members 18 years of age and older who received at least 180 treatment days of ACE inhibitors or ARBs during the measurement year and had at least one serum potassium and either a serum creatinine or a blood urea nitrogen therapeutic monitoring test in the measurement year. Annual monitoring for members on angiotensin converting enzyme inhibitors or angiotensin receptor blockers. This updates a previously published measure summary. Annual monitoring for patients on persistent medications: percentage of members 18 years of age and older who received at least 180 treatment days of anticonvulsants during the measurement year and had at least one drug serum concentration level monitoring test for the prescribed drug in the measurement year. Annual monitoring for members on anticonvulsants. This updates a previously published measure summary. Annual monitoring for patients on persistent medications: percentage of members 18 years of age and older who received at least 180 treatment days of digoxin during the measurement year and had at least one serum potassium and either a serum creatinine or a blood urea nitrogen therapeutic monitoring test in the measurement year. Annual monitoring for members on digoxin. This updates a previously published measure summary. Annual monitoring for patients on persistent medications: percentage of members 18 years of age and older who received at least 180 treatment days of diuretics during the measurement year and had at least one serum potassium and either a serum creatinine or a blood urea nitrogen therapeutic monitoring test in the measurement year. Annual monitoring for members on diuretics. This updates a previously published measure summary. Antidepressant medication management (effective acute phase treatment): percentage of members 18 years of age and older with a diagnosis of major depression and were newly treated with antidepressant medication, and who remained on an antidepressant medication for at least 84 days (12 weeks). This updates a previously published measure summary. Antidepressant medication management (effective continuation phase treatment): percentage of members 18 years of age and older with a diagnosis of major depression and were newly treated with antidepressant medication, and who remained on an antidepressant medication for at least 180 days (6 months). This updates a previously published measure summary. Cardiovascular monitoring for people with cardiovascular disease and schizophrenia: percentage of members 18 to 64 years of age with schizophrenia and cardiovascular disease who had an LDL-C test during the measurement year. Diabetes monitoring for people with diabetes and schizophrenia: percentage of members 18 to 64 years of age with schizophrenia and diabetes who had both an LDL-C test and an HbA1c test during the measurement year. Diabetes screening for people with schizophrenia or bipolar disorder who are using antipsychotic medications: percentage of members 18 to 64 years of age with schizophrenia or bipolar disorder who were dispensed an antipsychotic medication and had a diabetes screening test during the measurement year. Follow-up after hospitalization for mental illness: percentage of discharges for members 6 years of age and older who were hospitalized for treatment of selected mental health disorders and who had an outpatient visit, an intensive outpatient encounter, or partial hospitalization with a mental health practitioner within 30 days of discharge. This updates a previously published measure summary. Follow-up after hospitalization for mental illness: percentage of discharges for members 6 years of age and older who were hospitalized for treatment of selected mental health disorders and who had an outpatient visit, an intensive outpatient encounter, or partial hospitalization with a mental health practitioner within 7 days of discharge. This updates a previously published measure summary. Follow-up care for children prescribed ADHD medication (continuation and maintenance [C&M] phase): percentage of members 6 to 12 years of age with an ambulatory prescription dispensed for ADHD medication who remained on the medication for at least 210 days and who, in addition to the visit in the initiation phase, had at least two follow-up visits with a practitioner within 270 days (9 months) after the initiation phase ended. This updates a previously published measure summary. Follow-up care for children prescribed ADHD medication (initiation phase): percentage of members 6 to 12 years of age with an ambulatory prescription dispensed for ADHD medication who had one follow-up visit with a practitioner with prescribing authority during the 30-day initiation phase. This updates a previously published measure summary. Medication reconciliation post-discharge: percentage of discharges from January 1 to December 1 of the measurement year for members 66 years of age and older for whom medications were reconciled on or within 30 days of discharge. This updates a previously published measure summary. Potentially harmful drug-disease interactions in the elderly: percentage of Medicare members 65 years of age and older who have a diagnosis of CRF and a prescription for nonaspirin NSAIDs or Cox-2 selective NSAIDs. This updates a previously published measure summary. Potentially harmful drug-disease interactions in the elderly: percentage of Medicare members 65 years of age and older who have a diagnosis of dementia and a prescription for tricyclic antidepressants or anticholinergic agents. This updates a previously published measure summary. Potentially harmful drug-disease interactions in the elderly: percentage of Medicare members 65 years of age and older who have a history of falls and a prescription for tricyclic antidepressants, antipsychotics or sleep agents. This updates a previously published measure summary. Use of high-risk medications in the elderly: percentage of Medicare members 66 years of age and older who received at least one high-risk medication. This updates a previously published measure summary. Use of high-risk medications in the elderly: percentage of Medicare members 66 years of age and older who received at least two different high-risk medications. This updates a previously published measure summary. Withdrawn Summaries The summaries listed below have been withdrawn from the NQMC Web site because they are no longer in current use and therefore, do not meet the NQMC Inclusion Criteria. Please see the Measure Archive for a complete list of all measures that have been withdrawn from the NQMC Web site. Boston University Health & Disability Research Institute Post-acute care functional status: mean change score in applied cognitive function of patients in a post-acute care setting as assessed using the "Applied Cognition" domain of the Activity Measure for Post-acute Care (AM-PAC). Post-acute care functional status: mean change score in basic mobility of patients in a post-acute care setting as assessed using the "Basic Mobility" domain of the Activity Measure for Post-acute Care (AM-PAC). Post-acute care functional status: mean change score in daily activity of patients in a post-acute care setting as assessed using the "Daily Activities" domain of the Activity Measure for Post-acute Care (AM-PAC). Announcements Coming Soon New/Updated Institute for Clinical Systems Improvement Non-OR Procedural Safety Measures. Updated National Committee for Quality Assurance (NCQA) HEDIS 2013 Access and Availability of Care Measures and Utilization Measures. Look for these measures in NQMC in the near future! Health Awareness Topics -- September 2013 National Atrial Fibrillation Awareness Month (see related measures) Newborn Screening Awareness Month (see related measures) Prostate Cancer Awareness Month (see related measures) How to Participate Submit measures: Visit our Submit Measures page for information on how to submit your organization's measures. Suggest a measure for possible inclusion: Submit your suggestions for evidence-based quality measures and measure sets that you would like to see included in NQMC. NQMC Sister Resources Find Innovations and QualityTools classified by disease or clinical category, patient population, setting of care, stage of care, and more in AHRQ's Health Care Innovations Exchange Web site. Look for evidence-based clinical practice guidelines in AHRQ's National Guideline Clearinghouse (NGC).    How satisfied are you with this e-mail bulletin? Give Us Your Feedback Subscriber Services: Change Your Profile | Unsubscribe | Help Stay Connected: Contact Us | Social Media This email was sent to buzzhairs.health@blogger.com using GovDelivery, on behalf of: Agency for Healthcare Research and Quality (AHRQ) · 540 Gaither Road · Rockville, MD 20850 · 301-427-1364